Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from DarioHealth ( (DRIO) ) is now available.
On July 10, 2025, DarioHealth Corp. announced the appointment of Steven M. Nelson as its President and Chief Commercial Officer. Mr. Nelson, who has been with the company since June 2024, previously held leadership roles at Contigo Health and Anthem, Inc. This appointment is expected to strengthen DarioHealth’s leadership team, leveraging Mr. Nelson’s extensive experience in the health and marketing sectors.
The most recent analyst rating on (DRIO) stock is a Buy with a $1.50 price target. To see the full list of analyst forecasts on DarioHealth stock, see the DRIO Stock Forecast page.
Spark’s Take on DRIO Stock
According to Spark, TipRanks’ AI Analyst, DRIO is a Neutral.
DarioHealth’s overall stock score reflects significant financial challenges despite growing revenues. The financial performance is the most crucial factor, with profitability and debt reliance being major concerns. The earnings call provided some optimism with client growth and expense improvements, while the technical and valuation analyses remain neutral. The recent credit agreement offers potential financial stability.
To see Spark’s full report on DRIO stock, click here.
More about DarioHealth
Average Trading Volume: 197,806
Technical Sentiment Signal: Sell
Current Market Cap: $31.15M
See more data about DRIO stock on TipRanks’ Stock Analysis page.